Bhopal: Medical professionals advise against moving frequently between heated indoor spaces and cold environments, as this sudden temperature change c.

A new study from Karolinska Institutet maps the cellular and molecular dynamics of human wound healing in exceptional detail.

Prexigebersen is under clinical development by Bio-Path and currently in Phase II for Relapsed Acute Myeloid Leukemia.

A new study from Karolinska Institutet maps the cellular and molecular dynamics of human wound healing in exceptional detail.

Are you struggling with chronic pain? You are not alone! Research has shown that chronic pain occurs in an estimated 35% of ...

Discover the powerful pain relief properties of sugar apple leaves. A collaborative study reveals their ability to fight pain and inflammation.

Inflammation is a natural process in the body that helps fight off infections and heal injuries. However, when inflammation becomes chronic, it can lead to detrimental effects on the body.

Below, experts share how to reduce your chances of developing chronic inflammation that might erode your health over time.

Ryoncil is part of a development programme for inflammatory diseases such as SR-aGvHD in adults, and biologic-res ...

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNFA" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel oral therapies for autoimmune and inflammatory conditions, ...

RYONCIL (remestemcel-L) is the first MSC product approved by FDA for any indication.RYONCIL is the first FDA-approved therapy for children aged 2 ...